New study tracks blood sugar in pregnant women to predict baby size
NCT ID NCT07231341
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 100 pregnant women with gestational diabetes to understand how their daily blood sugar patterns relate to their baby's growth. Participants wear a continuous glucose monitor for 14 days and have routine checkups. The goal is to learn which blood sugar patterns are linked to larger birth weight, helping improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2022
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Stated in eligibility criteria. According to in- and exculsion criteria the study population will be singleton pregnant women \> 18 years of age, with gestational diabetes mellitus (GDM) between gestational age (GA) 28+0 and 34+6, without poorly controlled chronic diseases who are non-smokers and not treated with systemic corticosteroids.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All singleton pregnant women with gestational diabetes mellitus (GDM) between gestational age (GA) 28+0 and 34+6 attending the obstetric outpatient clinic at Aarhus University Hospital, Aarhus, Denmark or Gødstrup Hospital, Herning, Denmark will be offered participation. Exclusion Criteria: * Pre-gestational diabetes * Age \< 18 years * Multiple pregnancies * Chronic disease that is not well-controlled and is expected to influence study outcomes (including inflammatory diseases such as rheumatologic, gastroenterological, etc.) * Treatment with systemic corticosteroids * Smoking * Women who are unable to understand the oral and written patient information
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gestational diabetes mellitus (GDM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, 8200, Denmark
-
Gødstrup Hospital
RECRUITINGHerning, 7400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bedside ultrasound reveal hidden stomach contents before C-Section?
- Can olive oil and nuts in early pregnancy ward off gestational diabetes?
- Does a Mother's weight change the chemistry of her breast milk?
- Which pill tames pregnancy diabetes better?
- Weekly shot after gestational diabetes may shield new mothers from metabolic syndrome
- Hidden toll of gestational diabetes: study probes emotional and social impact